Myriad Genetics, Inc. (MYGN)
NASDAQ·Healthcare·Medical - Diagnostics & Research
$5.33
+0.19%
Mkt Cap $529.85M
Analyst Ratings
Buy
0
Hold
4
Sell
0
Price Target (17 analysts)
$6.00
Range $6.00 – $6.00
Implied Upside
+12.6%
Consensus $6.00 vs current $5.33